Noble Financial Keeps Their Buy Rating on MAIA Biotechnology, Inc. (MAIA)
In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on MAIA Biotechnology, Inc. (MAIA – Research Report), ...
Forbes22d
Walmart’s New Logo Is Making The Internet Mad
For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...
Stockhouse22d
MAIA Biotechnology to Present at Biotech Showcase 2025
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for ...
Forbes23d
This YC Partner Just Raised $30 Million For An AI Startup Automating Paperwork For Biotech
CEO Surbhi Sarna's small team at Collate so far includes founding chief architect Jigish Patel and cofounder and CTO Nate Smith. Surbhi Sarna sold her last startup, nVision Medical, for $275 ...
ADVFN23d
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced Company ...
FiercePharma24d
Biogen, already a Sage partner and equity owner, offers to buy the rest of the neuro biotech
A yearslong partner of neuroscience player Sage, Biogen already owns 10.2% of the Cambridge, Massachusetts-based biotech, according to the filing. In its own press release, Sage called the ...
FOX 40 WICZ TV26d
MAIA Biotechnology to Present at Biotech Showcase 2025
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that ...